Intensive blood transfusion support in acquired hemophilia A
作者： Giuseppe Tagariello , Roberto Sartori , Paolo Radossi , Giorgio Gandini , Massimo Franchini
DOI: 10.1007/S00277-006-0222-1
关键词:
摘要:
springer.com
sci-hub.se 参考文章(11)
C R M Hay, C Negrier, C A Ludlam, The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thrombosis and Haemostasis. ,vol. 78, pp. 1463- 1467 ,(1997) , 10.1055/S-0038-1665434
Y. Sultan, Acquired hemophilia and its treatment. Blood Coagulation & Fibrinolysis. ,vol. 8, ,(1997)
MW Hilgartner, GL Knatterud, The Use of Factor Eight Inhibitor By-Passing Activity (FEIBA Immuno) Product for Treatment of Bleeding Episodes in Hemophiliacs With Inhibitors Blood. ,vol. 61, pp. 36- 40 ,(1983) , 10.1182/BLOOD.V61.1.36.36
Amy Shapiro, Inhibitor treatment: State of the art Seminars in Hematology. ,vol. 38, pp. 26- 34 ,(2001) , 10.1016/S0037-1963(01)90144-1
Julio Delgado, Victor Jimenez-Yuste, Fernando Hernandez-Navarro, Ana Villar, Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors British Journal of Haematology. ,vol. 121, pp. 21- 35 ,(2003) , 10.1046/J.1365-2141.2003.04162.X
Harold R. Roberts, The Use of Agents that By–Pass Factor VIII Inhibitors in Patients with Haemophilia Vox Sanguinis. ,vol. 77, pp. 38- 41 ,(1999) , 10.1159/000056714
R. Kashyap, V. P. Choudhry, M. Mahapatra, S. Chumber, R. Saxena, H. L. Kaul, Postpartum acquired haemophilia: clinical recognition and management. Haemophilia. ,vol. 7, pp. 327- 330 ,(2001) , 10.1046/J.1365-2516.2001.00506.X
Alice J. Cohen, Craig M. Kessler, 9 Acquired inhibitors Baillière's clinical haematology. ,vol. 9, pp. 331- 354 ,(1996) , 10.1016/S0950-3536(96)80067-9
C. R. M. Hay, T. P. Baglin, P. W. Collins, F. G. H. Hill, D. M. Keeling, The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO). British Journal of Haematology. ,vol. 111, pp. 78- 90 ,(2000) , 10.1046/J.1365-2141.2000.02327.X
M. FRANCHINI, D. GIRELLI, O. OLIVIERI, G. CASTAMAN, G. LIPPI, G. POLI, G. L. SALVAGNO, G. TAGARIELLO, A. GIUFFRIDA, M. DE GIRONCOLI, M. MORFINI, E. BERNTORP, G. GANDINI, Tyr2105Cys mutation in exon 22 of FVIII gene is a risk factor for the development of inhibitors in patients with mild/moderate haemophilia A Haemophilia. ,vol. 12, pp. 448- 451 ,(2006) , 10.1111/J.1365-2516.2006.01297.X